Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In patients with early PD, the GLP-1RA lixisenatide can modestly slow the progression of motor dysfunction over 12 months of treatment, but it is associated with gastrointestinal side effects, and its long-term efficacy and safety require further verification (265)
During hyperkalemia potassium secretion must be enhanced in order to prevent cardiac conductance and neuromuscular complications
10.1136/gut.2007.147496 Gut 166 SheuS
All dosing parameters and protocols referenced in this article are strictly for research contexts and do not constitute medical advice
Wang W, Kaelber DC, Xu R, Berger NA
Pronsato L, Milanesi L, Vasconsuelo A
US$ 26.32
US$ 29.01
US$ 24.57
US$ 28.96
US$ 26.88
